Biotest AG VZ Stock
Price
Target price
€30.00
€30.00
-3.310%
-1.0
-3.310%
-
06.06.25 / Tradegate
WKN: 522723 / Name: Biotest / Stock / Pharmaceuticals / Small Cap /
We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Financial data and news for Biotest
sharewise wants to provide you with the best news and tools for Biotest, so we directly link to the best financial data sources.
Financials
News
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-News: Biotest AG increases sales by 6% in financial year 2024
EQS-News: Biotest AG increases sales by 6% in financial year 2024
EQS-Adhoc: Biotest AG: CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.
EQS-Adhoc: Biotest AG: CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.
EQS-Adhoc: Biotest AG publishes preliminary business figures - 2024 forecasts partially exceeded
EQS-Adhoc: Biotest AG publishes preliminary business figures - 2024 forecasts partially exceeded
EQS-News: Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
EQS-News: Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)